StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3
Publishing Date
2021 - 08 - 05
3
Sector
Commercial services
1
Health technology
2
Tags
Acquired
3
Acquisition
10
Alliances
5
Application
3
Authorized
4
Biopharma
5
Bioscience
5
Biotech
5
Biotech-bay
4
Biotech-beach
4
Brands
4
Cancer
9
Clinical-trials-phase-iii
4
Communication
8
Communications
8
Conference
50
Contract
3
Covid
6
Device
4
Disease
5
Distribution
4
Drug
5
Earnings
29
Energy
8
Europe
3
Ev
7
Events
15
Expansion
4
Financial results
116
Food
4
Funding
3
Growth
31
Health
6
Hotel
4
India
5
Internet
4
Iot
8
Lung cancer
4
Merge
6
Mobile
4
Money
5
N/a
471
Offering
11
Partnership
5
People
5
Pharma
12
Phase 3
6
Positive
4
Program
5
Report
35
Research
8
Results
217
Sales
4
Software
4
Technology
11
Test
5
Therapy
6
Treatment
6
Trial
14
Vaccine
5
Entities
Exicure, inc.
1
Igm biosciences, inc.
1
Monopar therapeutics inc.
1
Symbols
IGMS
1
MNPR
1
XCUR
1
Exchanges
Nasdaq
3
Crawled Date
2023 - 01 - 09
4
2022 - 12 - 15
4
2022 - 12 - 13
4
2022 - 10 - 26
5
2022 - 06 - 29
4
2022 - 06 - 06
4
2022 - 06 - 02
5
2022 - 04 - 26
4
2022 - 04 - 04
4
2022 - 01 - 26
3
2022 - 01 - 24
4
2022 - 01 - 20
5
2022 - 01 - 05
4
2021 - 12 - 16
4
2021 - 12 - 15
4
2021 - 12 - 13
5
2021 - 12 - 06
5
2021 - 12 - 01
4
2021 - 11 - 30
4
2021 - 11 - 15
4
2021 - 11 - 12
3
2021 - 11 - 11
3
2021 - 10 - 27
3
2021 - 10 - 19
3
2021 - 10 - 13
3
2021 - 10 - 07
3
2021 - 10 - 04
4
2021 - 10 - 01
5
2021 - 09 - 30
3
2021 - 09 - 29
4
2021 - 09 - 13
6
2021 - 09 - 09
6
2021 - 09 - 08
5
2021 - 08 - 31
4
2021 - 08 - 25
3
2021 - 08 - 23
3
2021 - 08 - 05
3
2021 - 07 - 26
5
2021 - 07 - 22
3
2021 - 07 - 09
4
2021 - 06 - 30
4
2021 - 06 - 24
4
2021 - 06 - 23
5
2021 - 06 - 16
3
2021 - 06 - 10
3
2021 - 06 - 09
3
2021 - 06 - 08
3
2021 - 06 - 02
3
2021 - 05 - 12
3
2021 - 04 - 20
6
2021 - 04 - 15
3
2021 - 03 - 24
3
2021 - 03 - 15
4
2021 - 03 - 09
3
2021 - 02 - 24
3
2021 - 01 - 27
3
2020 - 12 - 15
5
2020 - 12 - 10
3
2020 - 12 - 08
3
2020 - 12 - 01
4
Crawled Time
08:00
1
12:15
2
Source
www.biospace.com
1
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Phase 2b
crawled date :
2021 - 08 - 05
save search
Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod (AST-008)
Published:
2021-08-05
(Crawled : 12:15)
- biospace.com/
XCUR
4
|
$0.515
19K
|
Commercial Services
|
-63.12%
|
O:
-1.42%
H:
1.44%
C:
-5.04%
ongoing
phase 1
results
trial
phase 1b
phase 2b
Monopar Reaches Target Number of Clinical Sites in Phase 2b Portion of 2b/3 Validive® VOICE Trial
Published:
2021-08-05
(Crawled : 12:15)
- globenewswire.com
MNPR
|
$0.657
1.08%
-3.17%
31
|
Health Technology
|
-87.06%
|
O:
3.92%
H:
0.38%
C:
-1.7%
phase 2
phase 2b
trial
Data from Medivir's MIV-818 phase 1b study to be presented at the ESMO Congress
Published:
2021-08-05
(Crawled : 08:00)
- prnewswire.com
IGMS
|
$7.96
3.38%
3.14%
27
|
Health Technology
|
-88.49%
|
O:
-0.49%
H:
15.53%
C:
14.73%
phase 1
phase 1b
phase 2b
Gainers vs Losers
50%
50%
Top 10 Gainers
CSSE
4
|
$0.299
96.32%
7M
|
Consumer Services
BRFH
4
|
$1.99
80.91%
13M
|
Manufacturing
BOF
|
$1.915
63.68%
620K
|
AMST
|
$3.13
56.5%
500K
|
Technology Services
ACON
|
$0.3595
24.83%
3.5M
|
n/a
CDTX
|
News
|
$14.57
18.55%
330K
|
Health Technology
ULBI
M
|
$10.12
15.92%
120K
|
Producer Manufacturing
LRHC
|
$1.79
11.88%
3K
|
n/a
AIXI
|
$1.34
8.94%
42K
|
n/a
TRU
|
$74.475
8.44%
100K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.